Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 stud... von Passaro, A, Wang, J, Wang, Y, Lee, S-H, Melosky, B, Shih, J-Y, Wang, J, Azuma, K, Juan-Vidal, O, Cobo, M, Felip, E, Girard, N, Cortot, A B, Califano, R, Cappuzzo, F, Owen, S, Popat, S, Tan, J-L, Salinas, J, Tomasini, P, Gentzler, R D, William, Jr, W N, Reckamp, K L, Takahashi, T, Ganguly, S, Kowalski, D M, Bearz, A, MacKean, M, Barala, P, Bourla, A B, Girvin, A, Greger, J, Millington, D, Withelder, M, Xie, J, Sun, T, Shah, S, Diorio, B, Knoblauch, R E, Bauml, J M, Campelo, R G, Cho, B C

Volltext

Therapeutic antibodies: A new era in the treatment of respiratory diseases? von Sécher, T., Guilleminault, L., Reckamp, K., Amanam, I., Plantier, L., Heuzé-Vourc'h, N.

Volltext

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer von Carter, C.A., Rajan, A., Keen, C., Szabo, E., Khozin, S., Thomas, A., Brzezniak, C., Guha, U., Doyle, L.A., Steinberg, S.M., Xi, L., Raffeld, M., Tomita, Y., Lee, M.J., Lee, S., Trepel, J.B., Reckamp, K.L., Koehler, S., Gitlitz, B., Salgia, R., Gandara, D., Vokes, E., Giaccone, G.

Volltext

SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment von Figueiredo, J.C., Ihenacho, U., Merin, N.M., Hamid, O., Darrah, J., Gong, J., Paquette, R., Mita, A.C., Vescio, R., Mehmi, I., Basho, R., Salvy, S.J., Shirazipour, C.H., Caceres, N., Finster, L.J., Coleman, B., Arnow, H.U., Florindez, L., Sobhani, K., Prostko, J.C., Frias, E.C., Stewart, J.L., Merchant, A., Reckamp, K.L.

Volltext

ES14.05 Patients Harbouring a Driven-Mutation: Pro and Patient's Perspective von Reckamp, K.

Volltext

Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer von Korbakis, D, Dimitromanolakis, A, Prassas, I, Davis, G J, Barber, E, Reckamp, K L, Blasutig, I, Diamandis, E P

Volltext

PC04.02 Optimal Sequencing of EGFR TKI Therapy - 3rd Generation First von Reckamp, K.

Volltext

Phase IV, open-label, multicentre trial of afatinib in patients (pts) aged ≥70 yrs with NSCLC harbouring common (Del19/L858R) EGFR mutations: Preliminary results von Reckamp, K.L., Gilman, P., Halmos, B., Jahanzeb, M., McCann, J., Paripati, H., Seneviratne, L.C., Wallace, J.A., Rueter, B., Esler, A., Dowling, E., Koczywas, M.

Volltext

Intracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC) von Wakelee, H., Reckamp, K.L., Leal, T.A., Patel, S.P., Blumenschein, G., Shum, E., Nieva, J., Oxnard, G., Sanborn, R.E., Waqar, S., Zeman, K., Dukart, G., Harrow, K., Liang, C., Holzhausen, A., Horn, L.

Volltext

The FEN1 E359K germline mutation disrupts the FEN1–WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers von Chung, L, Onyango, D, Guo, Z, Jia, P, Dai, H, Liu, S, Zhou, M, Lin, W, Pang, I, Li, H, Yuan, Y-C, Huang, Q, Zheng, L, Lopes, J, Nicolas, A, Chai, W, Raz, D, Reckamp, K L, Shen, B

Volltext

Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) von Horn, L., Whisenant, J.G., Wakelee, H., Reckamp, K.L., Qiao, H., Du, L., Hernandez, J., Huang, V., Waqar, S.N., Patel, S., Sanborn, R.E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., Lim, L.P., Li, M., Lovly, C.M.

Volltext

Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors von Koczywas, M, Frankel, P H, Synold, T W, Lenz, H-J, Mortimer, J E, El-Khoueiry, A B, Gandara, D R, Cristea, M C, Chung, V M, Lim, D, Reckamp, K L, Lau, D H, Doyle, L A, Ruel, C, Carroll, M I, Newman, E M

Volltext

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer von Blumenschein Jr, G.R., Kabbinavar, F., Menon, H., Mok, T.S.K., Stephenson, J., Beck, J.T., Lakshmaiah, K., Reckamp, K., Hei, Y.-J., Kracht, K., Sun, Y.-N., Sikorski, R., Schwartzberg, L.

Volltext

3094 Nivolumab (NIVO) safety profile: Summary of findings from trials in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC) von Gettinger, S.N, Horn, L, Ramalingam, S.S, Spigel, D.R, Paz-Ares, L, Paik, P, Reck, M, Reckamp, K, Mazières, J, Stinchcombe, T, Lynch, M, Brahmer, J

Volltext

1547 Interdisciplinary palliative care for lung cancer patients and family caregivers von Koczywas, M, Sun, V, Hurria, A, Cristea, M, Raz, D.J, Kim, J.Y, Reckamp, K, Zachariah, F, Williams, A.C, Borneman, T, Fujinami, R, Del Ferraro, C, Uman, G, Ferrell, B

Volltext

Baseline Urinary PGE-M Is a Prognostic and Predictive Marker for Cox-2 Inhibition in Addition to Standard Chemotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC): CALGB 30801... von Edelman, M.J, Wang, X, Hodgson, L, Milne, G.L, Cheney, R, Baggstrom, M, Sachdev, T, Gajra, A, Bertino, E, Reckamp, K, Molina, J, Schiller, J, Mitchell-Richards, K, Friedman, P, Ritter, J, Vokes, E

Volltext

3088 Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test von Gadgeel, S, Soria, J.C, Goldman, J.W, Wakelee, H, Camidge, D.R, Yu, H, Varga, A, Solomon, B, Oxnard, G.R, Ou, S.H, Papadimitrakopoulou, V, Liu, S.V, Reckamp, K, Spira, A, Piotrowska, Z, Despain, D, Karlovich, C, Yurasov, S, Sequist, L.V

Volltext

3105 Dose optimization of rociletinib for EGFR mutated NSCLC: Benefit/risk analysis from the TIGER-X trial von Soria, J.C, Goldman, J.W, Wakelee, H, Gadgeel, S, Camidge, D.R, Solomon, B, Yu, H, Oxnard, G.R, Ou, S.H, Papadimitrakopoulou, V, Perol, M, Reckamp, K, Varga, A, Dziadziuszko, R, Chouaid, C, Cortot, A, Do, P, Moro-Sibilot, D, Poudenx, M, Sequist, L.V

Volltext

A phase I study of bortezomib and temozolomide in patients with advanced solid tumors von Portnow, J., Frankel, P., Koehler, S., Twardowski, P., Shibata, S., Martel, C., Morgan, R., Cristea, M., Chow, W., Lim, D., Chung, V., Reckamp, K., Leong, L., Synold, T. W.

Volltext

EP.03G.01 Comparison of Tumor Immune Microenvironments Between Primary and Metastatic Sites in Non-Small Cell Lung Cancer von Sankar, K., Mercer, J., Jaeger, E., Godden, J., Williams, E., Thompson, M., Patel, S., Reckamp, K., Weinberg, F.

Volltext